Oxidized LDL and anti-oxidized LDL antibodies in atherosclerosis - Novel insights and future directions in diagnosis and therapy

被引：107
|
作者：
Hartley, Adam [1 ]
Haskard, Dorian [1 ]
Khamis, Ramzi [1 ]
机构：
[1] Imperial Coll London, Natl Heart & Lung Inst, Hammersmith Hosp Campus,Cane Road, London W12 0NN, England
来源：
TRENDS IN CARDIOVASCULAR MEDICINE | 2019年 / 29卷 / 01期
关键词：
Oxidized low-density lipoprotein; Atherosclerosis; Vulnerable plaque; LOW-DENSITY-LIPOPROTEIN; OXIDATION-SPECIFIC EPITOPES; APOLIPOPROTEIN B-100; IMMUNE-COMPLEXES; CARDIOVASCULAR EVENTS; IGM AUTOANTIBODIES; MDA-LDL; CORONARY; BIOMARKERS; DISEASE;
D O I：
10.1016/j.tcm.2018.05.010
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
We provide an up-to-date overview of current topics surrounding oxidized low-density lipoprotein (oxLDL) and its related antibodies in the quest to better identify the individuals at risk of cardiovascular disease and atherosclerotic plaques with unfavorable characteristics. We discuss the potential of oxLDL and anti-oxLDL antibodies as serum biomarkers of cardiovascular disease and emerging studies examining the targeting of arterial oxLDL for imaging and therapeutic delivery. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码：22 / 26
页数：5
相关论文
共 50 条
  • [31] Carbamylated LDL but not oxidized LDL is associated with atherosclerosis in uremic patients
    Basnakian, Alexei G.
    Apostolov, Eugene O.
    Ok, Ercan
    Yin, Xiaoyan
    Altunel, Ekrem
    Shah, Sudhir V.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 434 - 434
  • [32] Atherosclerosis and anti-oxidized low density lipoprotein antibodies in an elderly population
    Balada, E
    Ordi-Ros, J
    Matas, L
    Mauri, M
    Vilardell-Tarrés, SBYM
    [J]. MEDICINA CLINICA, 2002, 119 (05): : 161 - 165
  • [33] Increased susceptibility of SLE patients with anti-Ro 60, La and Ro 52 to develop anti-oxidized LDL: Development of anti-oxidized LDL and IgG APL antibodies prior to anti-Ro 60 onset in a lupus patient.
    Kurien, Biji T.
    Fesmire, James
    Hal Scofield, R.
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S297 - S297
  • [34] Antibodies against oxidized LDL in infants
    Steinerová, A
    Stozicky, F
    Racek, J
    Tatzber, F
    Zima, T
    Stetina, R
    [J]. CLINICAL CHEMISTRY, 2001, 47 (06) : 1137 - 1138
  • [35] RECOGNITION OF OXIDIZED LDL BY ANTICARDIOLIPIN ANTIBODIES
    PARTHASARATHY, S
    JACKSON, EH
    MURPHY, AA
    AGARWAL, M
    [J]. CIRCULATION, 1995, 92 (08) : 3002 - 3002
  • [36] Antibodies to oxidized LDL in atherosclerosis development-clinical and animal studies
    Hulthe, J
    [J]. CLINICA CHIMICA ACTA, 2004, 348 (1-2) : 1 - 8
  • [37] Anti-idiotypes to oxidized LDL antibodies in intravenous immunoglobulin preparations - Possible immunomodulation of atherosclerosis
    Wu, RH
    Shoenfeld, Y
    Sherer, Y
    Patnaik, M
    Matsuura, E
    Gilburd, B
    Koike, T
    Peter, JB
    [J]. AUTOIMMUNITY, 2003, 36 (02) : 91 - 97
  • [38] Oral tolerance to oxidized LDL ameliorates atherosclerosis
    van Puijvelde, GH
    de Vos, P
    van den Heuvel, R
    Hauer, AD
    van der Zee, R
    van Eden, W
    Berkel, T
    Kuiper, J
    [J]. CIRCULATION, 2004, 110 (17) : 208 - 209
  • [39] Impact of plasma oxidized LDL removal on atherosclerosis
    Ishigaki, Yasushi
    Katagiri, Hideki
    Gao, Junhong
    Oka, Yoshitomo
    [J]. DIABETES, 2008, 57 : A200 - A200
  • [40] Oxidized LDL, LOX-1 and Atherosclerosis
    Sona Mitra
    Tanu Goyal
    Jawahar L. Mehta
    [J]. Cardiovascular Drugs and Therapy, 2011, 25 : 419 - 429
12345